Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trialDavid E. Kandzari, Denise Reedus, Garrett Pilcher et al.|The Lancet|2018Cited by 775
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trialRaymond R. Townsend, Felix Mahfoud, David E. Kandzari et al.|The Lancet|2017Cited by 734
Long-Term Outcome of Percutaneous Coronary Intervention for Chronic Total OcclusionsRoxana Mehran, Antonio Colombo, Bimmer E. Claessen et al.|JACC: Cardiovascular Interventions|2011Cited by 310
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trialsMarco Valgimigli, Roxana Mehran, Felice Gragnano et al.|BMJ|2021Cited by 254
Reperfusion Injury in Patients With Acute Myocardial InfarctionFrederick G.P. Welt, Navin K. Kapur, Wayne Batchelor et al.|Journal of the American College of Cardiology|2024Cited by 169